|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Upper Respiratory Tract Infection | |||||
| Lower Respiratory Tract Infection | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Communicable Diseases | |||||
| Infection | |||||
| Respiratory Tract Infections | |||||
| 3 | More general conditions related to this trial | ||||
| Respiratory Tract Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| RI-001 | |||||
| 5 | Sponsors listed in this trial | ||||
| ADMA Biologics, Inc. | |||||